CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Scientific Officer acquired 48,140 shares (grant or award)
- 4 Open-market sale Chief Scientific Officer sold 100,000 shares at $3.61 ($361,000)
- 4 Shares withheld for taxes CFO and Treasurer gave up 1,256 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel, Secretary gave up 1,435 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 1,426 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel, Secretary gave up 1,629 shares (to pay taxes)
- 4 Grant or award General Counsel, Secretary acquired 40,000 shares (grant or award)
- 4 Open-market sale CFO and Treasurer sold 36,955 shares at $8.26 ($305,248)
- 4 Open-market sale Director sold 19,500 shares at an average $7.83 ($152,635)
- 4 Other disposition 10% owner disposed of 7,024,208 shares (other)
- 4 Other disposition Director disposed of 7,024,208 shares (other)
- 4 Other acquisition Director acquired 500,182 shares (other)
- 4 Open-market sale Chief Scientific Officer sold 20,000 shares at an average $10.00 ($200,070)
- 4 Other disposition Director disposed of 748,694 shares (other)
- 4 Other disposition 10% owner disposed of 748,694 shares (other)
- 4 Other acquisition Director acquired 139,912 shares (other)
- 4/A Grant or award Chief Medical Officer acquired 152,335 shares (grant or award)
- 4 Shares withheld for taxes General Counsel, Secretary gave up 1,472 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 1,840 shares (to pay taxes)
Page 10 of 13 · 246 filings